Back to search
FDAFDA · Food and drugs·Recall number D-1249-2014

JaDera, 100% Natural Weight Loss Supplement, capsules, 30 count bottle

Published April 30, 2014 · Recall initiated: May 20, 2013

Summary

FDA records drug Class I recall D-1249-2014, published April 30, 2014 and initiated May 20, 2013. Recalling firm: Dolphin Intertrade Corporation; Status: Terminated; Reported quantity: 998 boxes; Lot: Manufacturing Codes: 10.06.2011 Exp. 09.06.2013. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed without an Approved NDA/ANDA: Products found to contain undeclared sibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Dolphin Intertrade Corporation
Distributor
Nationwide
Lot
Manufacturing Codes: 10.06.2011 Exp. 09.06.2013
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was JaDera, 100% Natural Weight Loss Supplement, capsules, 30 count bottle recalled?

Yes. FDA published recall D-1249-2014 on April 30, 2014. Reported hazard: Marketed without an Approved NDA/ANDA: Products found to contain undeclared sibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail